Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Temperature Imaging Application Illuminates Pathogenesis of Cancer and Other Diseases

By BiotechDaily International staff writers
Posted on 11 Feb 2013
Japanese researchers are investigating the functions of messenger ribonucleic acid (mRNA) has found a way to take a close look at the temperature distribution inside living cells. This new approach may lead to a better determination of diseases, such as cancer, which generates considerable intracellular heat.

This advance is the first time that the actual temperature distribution has been shown inside living cells. The investigators presented their findings at the 57th annual meeting of the Biophysical Society (BPS), held February 2-6, 2013, in Philadelphia (PA, USA).

Traditional temperature imaging techniques are deficient in spatial resolution and sensitivity, meaning these approaches are not capable of imaging very tiny temperature differences inside living cells. To resolve these problems, the scientists developed a new imaging application that combines a highly sensitive thermometer with an incredibly accurate detection technique, enabling the creation of detailed intracellular temperature maps.

“Our imaging method allows us to clearly see the temperature inside living cells, and we found that the temperature differs greatly depending on the location in the cell,” said Dr. Kohki Okabe, an assistant professor at the University of Tokyo’s (Japan) laboratory of bioanalytical chemistry, Graduate School of Pharmaceutical Science. “We discovered that the temperature difference is related to the various stages of the cell cycle.”

This research provides a unique point of view: Temperature not only regulates biologic molecules, but it in reality contributes to cellular functions. “By incorporating cellular temperature mapping into the analysis of any kind of cellular event, we can achieve a deeper understanding of cellular functions,” Dr. Okabe explained. “It is our hope that by using this method of temperature imaging, the pathogenesis of diseases known to generate significant heat within cells, such as cancer, can be clarified. We believe this may help lead to future cures.”

Dr. Okabe and coworkers now plan to research how temperature contributes to cellular functions in even greater detail, as well as examine discrepancies in the intracellular temperatures of a range of living cells.

Related Links:
University of Tokyo




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.